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Parasitic helminths are potent regulators of host immunity, including inhibition of allergic inflammation. In this
issue of Immunity, Zaiss et al. (2015) reveal that microbiota compositional shifts during helminth infection
contribute to the multifaceted ways that helminths modulate host immunity.The primary goal for a parasite is to
remain within their host for as long as
possible, while finding ways to propa-
gate. There is little doubt that helminths
are successful in achieving this goal, as
demonstrated by their ability to mount
chronic infections in mammalian hosts.
Approximately two billion people world-
wide are currently infected with hel-
minths; many infections last for several
years, and some even persist for de-
cades. The success of these parasites
is attributed to their capacity to modulate
host immune responses, which helps
their continued colonization and prevents
their expulsion. The immunomodulatory
capabilities of helminths have a broad
scope, extending to suppression of im-
mune responses against foreign antigens
and allergens. Thus, helminths or hel-
minth excretory-secretory products have
the potential to be used therapeutically
in the treatment of allergic diseases
(McSorley et al., 2013). Given that hel-
minth infection alters the composition of
the bacterial intestinal microbiota (Rey-
nolds et al., 2015) and that the microbiota
composition has been implicated in influ-
encing allergic disease (McCoy and Ko¨l-
ler, 2015), a major unanswered question
is: to what extent does helminth infectionreduce allergic inflammation through ef-
fects on the microbiota?
In this issue of Immunity, Zaiss et al.
(2015) present evidence that one pathway
by which helminth infection dampens
allergic inflammation occurs as a result
of compositional shifts within the intesti-
nal microbiota. First, they have shown
that infectingmicewith the intestinal nem-
atode parasite Heligmosomoides polygy-
rus reduced airway inflammation in a
house dust mite (HDM)-induced model
of allergy, consistent with previous re-
ports of helminths suppressing allergy
(McSorley et al., 2013). Next, Zaiss et al.
(2015) reported the striking observation
that the helminth-induced protection
from airway inflammation is abrogated in
mice that had been given antibiotics, sug-
gesting that the intestinal microbiota is
required for suppression of airway inflam-
mation. Importantly, antibiotic treatment
did not affect H. polygyrus numbers.
Moreover, co-housing with H. polygyrus-
infected mice, or transferring cecal con-
tents from H. polygyrus-infected mice to
uninfected recipients, resulted in protec-
tion from HDM-induced inflammation.
The authors confirmed that H. polygyrus
infection was unable to be transferred to
recipient mice during these experiments,suggesting that a transferable component
of the helminth-modified microbiota was
able to provide protection from airway
inflammation.
Compositional shifts within the intesti-
nal bacterial microbiota have been previ-
ously associated with susceptibility to
allergic disease, after alterations in diet
or the administration of antibiotics
(McCoy and Ko¨ller, 2015). How could mi-
crobiota shifts during helminth infection
contribute to reduced airway inflamma-
tion? Zaiss et al. (2015) show that
H. polygyrus-infected mice, or mice
receiving a H. polygyrus-modulated mi-
crobiota, had elevated cecal amounts
of short chain fatty acids (SCFA). They
demonstrated that H. polygyrus itself
was capable of generating the SCFA ace-
tate in in vitro cultures (Zaiss et al., 2015).
Indeed, several other helminth species
have been shown to produce acetate
(Tielens et al., 2010). Because antibi-
otic-treated H. polygyrus-infected mice
showed completely abrogated SCFA pro-
duction, it is likely that the major source of
SCFA generated during H. polygyrus
infection was the bacterial microbiota,
rather than the parasites themselves
(Zaiss et al., 2015). They further demon-
strated that elevated SCFA levels are a
Figure 1. Converging Helminth- andMicrobiota-Derived Pathways Induce Suppressive Treg
Cells, Resulting in Dampened Allergic Airway Inflammation
Helminth infection results in compositional shifts within intestinal bacteria populations, through as yet
unclear mechanisms, which are probably both direct and indirect (Reynolds et al., 2015). Helminth par-
asites themselves have been shown to produce the SCFA acetate (Tielens et al., 2010; Zaiss et al., 2015),
but themajor generators of SCFA during helminth infection are the bacterial microbiota (Zaiss et al., 2015).
SCFA signal in a GPR41-dependent manner to increase the suppressive capacity of Treg cells (Zaiss
et al., 2015). The cell type on which GPR41 expression is required is unknown. Direct effects of helminth
products leading to the induction of Treg cells have also been demonstrated, for example the excretory-
secretory product of H. polygyrus (HES), which signals through TGF-bR expression on CD4+ T cells
(Grainger et al., 2010). Heightened activity of Treg cells is associated with reduced type 2 cytokine pro-
duction in the airways and reduced eosinophil recruitment, after exposure to allergens such as HDM (Zaiss
et al., 2015).
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mammals, as both Ascaris suum-infected
pigs and humans infected with Nector
americanus had measurable increases in
intestinal SCFA. SCFA administration
has previously been shown to reduce
HDM-induced airway inflammation in a
manner dependent on the G protein-
coupled receptor (GPR)41 (Trompette
et al., 2014). Moreover, Zaiss et al.
(2015) report that GPR41 was necessary
both for the induction of suppressive reg-
ulatory T (Treg) cells and the inhibition of
airway inflammation during helminth
infection. Together, this suggests that
bacterially derived SCFA are a major
mediator of inhibited airway inflammation
during helminth infection.
Analysis of the H. polygyrus-modified
microbiota revealed an association be-
tween SCFA concentrations and bacteria
belonging to the family Lachnospiraceae
(Zaiss et al., 2015). It is now clear that mi-
crobiota compositional changes occur
during infection with a variety of helminth
species and that importantly these
changes have an impact on the func-
tional capability of the microbiota (Rey-
nolds et al., 2015). What is less clear
are the routes by which helminth infec-tion results in these population shifts.
Helminths release a suite of excretory-
secretory products, and infection results
in altered nutrient availability and an
altered local immune environment; all of
these factors probably contribute to
shaping the microbiota composition.
However, this relationship is bi-direc-
tional, because the microbiota composi-
tion also affects the persistence of intes-
tinal helminths within the host (Reynolds
et al., 2015). This raises the intriguing
possibility that microbial shifts during
infection might be advantageous to the
helminth, triggering host immunomodula-
tory pathways that promote the survival
of both organisms.
Allergic disease is not the only context
in which helminth infection dampens
host immune responses. Helminth infec-
tion or the administration of helminth
products can reduce disease severity in
several chemically induced mouse
models of inflammatory bowel disease
(McSorley et al., 2013). Helminth co-
infection can also result in reduced im-
munity to bacterial and viral pathogens,
as well as to protozoan parasites such
as malaria-causing Plasmodium (Os-
borne et al., 2014; Reese et al., 2014;Immunity 43, NReynolds et al., 2015; Salgame et al.,
2013). The contribution of the helminth-
modified microbiota to immune modula-
tion in these settings remains largely un-
explored. However, in a mouse model
of viral infection, helminth co-infection in-
hibits anti-viral immune responses and
leads to increased viral loads both in
specific-pathogen-free mice and germ-
free mice, indicating that in this context
helminth-induced immunomodulation
occurs independently of the microbiota
(Osborne et al., 2014). This highlights
that helminth-induced microbiota alter-
ations are not the sole mediator of host
immunomodulation and emphasizes the
need for further studies to determine to
what extent helminths exert their effects
through the microbiota in different dis-
ease settings.
This study raises a number of inter-
esting questions for future investigation.
It is known that soluble excretory-secre-
tory products produced by several hel-
minth species can inhibit inflammation in
mouse models without the presence of a
live helminth infection (McSorley et al.,
2013). Whether the microbiota contribute
to the action of these products in the
absence of infection is unclear, as many
direct effects of helminth products on
host immune responses have been
described (McSorley et al., 2013). For
example, excretory-secretory products
from H. polygyrus (HES) can directly
induce Foxp3 expression in naive CD4+
T cells, resulting in the production of func-
tionally suppressive Treg cells (Grainger
et al., 2010). How helminth products act
in synergy with microbiota-derived prod-
ucts will be an important focus for future
research. It is becoming increasingly clear
that both helminths and members of the
bacterial microbiota target converging
immune pathways within the host (Rey-
nolds et al., 2015) with the aim of ensuring
their own survival and with the resulting
effect of dampened host inflammatory
responses (Figure 1).
There is substantial evidence that hel-
minth infection reduces inflammation in
response to allergen exposure (McSorley
et al., 2013), but live helminths are unlikely
to be adopted as a treatment strategy.
Instead, efforts have thus far focused on
identifying helminth excretory-secretory
products with immunomodulatory capac-
ity (McSorley et al., 2013). Importantly,
Zaiss et al. (2015) now demonstrate forovember 17, 2015 ª2015 Elsevier Inc. 841
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Previewsthe first time that part of the immunomod-
ulatory effects of helminth infection func-
tion via the microbiota, opening up the
possibility that live microbes or micro-
biota-derived products could be com-
bined with helminth products as addi-
tional therapeutic candidates. There is
no doubt that dissecting the multidirec-
tional interactions between parasites, the
microbiota, and the host immune system
is indeed challenging, but Zaiss et al.
(2015) have brought our attention to the
microbiota, which have now wormed
their way into our understanding of how
helminths manipulate the mammalian im-
mune system.842 Immunity 43, November 17, 2015 ª2015REFERENCES
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How immune tolerance is maintained in the skin remains unclear. In this issue of Immunity, Rosenblum and
colleagues demonstrate that tolerance to commensal bacteria is established during the neonatal period via
regulatory T cells. Defining the crucial window during which commensal-specific tolerance is achieved has
strategic implications for the induction of tolerance in allergic diseases.The skin is the outermost immunological
interface that harbors vast numbers of
resident leukocytes that provide surveil-
lance against pathogens while tolerating
millions of commensal microbes. The
important role of resident memory T cells
in conferring protective immunity in the
skin has been well recognized over the
last several years (Heath and Carbone,
2013). Meanwhile, pioneering micro-
biome studies have elucidated the land-
scape of the skin microbiota in health
and disease (Grice et al., 2009; Kong
et al., 2012), providing an impetus to
further explore the cross talk between
commensal bacteria and the immune sys-
tem. In the absence of skin commensals,
resident T cells in the skin are unable to
acquire proper effector states to exert
protective immunity against pathogens,
highlighting the importance of commen-sals in tuning skin immunity (Heath and
Carbone, 2013).
Regulatory T (Treg) cells are crucial for
the maintenance of systemic immune ho-
meostasis. Gastrointestinal Treg cells are
tuned by commensal bacteria to mediate
tolerance (Atarashi et al., 2011), and
mice that either have dysfunctional Treg
cells or lack them entirely spontaneously
develop inflammatory colitis (Ramsdell
and Ziegler, 2014). Given the abundance
of lymphocytes in the skin, it is reasonable
to hypothesize that a strict checkpoint
should exist for regulating excessive
immune responses—otherwise, lympho-
cytes would respond against commen-
sals, leading to uncontrolled skin inflam-
mation. The classic scurfy mouse
mutant, which has a FoxP3 mutation re-
sulting in impaired Treg cell differentiation
and severe skin inflammation, demon-strates that Treg cells are required for
the regulation of skin immune homeosta-
sis (Ramsdell and Ziegler, 2014). Whether
or not Treg cells are involved in inducing
tolerance against skin commensals and
thereby contribute to skin immune ho-
meostasis had not been previously
studied.
In this issue of Immunity, Scharschmidt
et al. develop a novel tool and an in vivo
assay to address the role of bacteria
in the induction of commensal-specific
Treg cells in the skin (Scharschmidt
et al., 2015). The authors’ utilization of
Staphylococcus epidermidis as a proto-
type is appropriate because S. epidermi-
dis is prevalent as a human commensal
and is also capable of colonizing mouse
skin. In this work, S. epidermidis is genet-
ically engineered to express the model
T cell antigen, 2W (Epi-2W), to enable
